The dynamics in ag retail are evolving. The wholesale layer is being reassessed. Downstream, the programs, rebates and return privileges that the manufacturer-and-distributor structure paid for are funded out of a profit pool that is shrinking.
Jerry Miller, vice president of agronomy at Sunrise Cooperative, puts it in one line: “All the margin the basic manufacturer had has now been eroded.”
The evidence shows up in routines that no longer run.
“Actions that we’ve done for 30 years — summer fills with our main partners — those summer fills are not happening for us because that market is on its heels. We’ll see where that all lands. But it’s uncomfortable for a lot of people right now,” Miller says.
He gives the recent example of Roundup PowerMax being dropped $2 a gallon after the product had been price-protected through April 2027.
“So if you just loaded with generic, you got the pleasure of owning it, and now branded would be less cost. That’s one of the struggles in that market,” Miller says.
Glyphosate products are just one example, but it’s the go-to example of the dynamics in the industry.
Supplier Dynamics
Based on analysis from Wesley Davis at Meridian Ag Advisers, off-patent chemistry represents 65% of North American volumes. There will be 36 active ingredients that go off patent in the five years spanning 2025 and 2029.
“If you think about the overall profit pool for agrochemicals as an industry, as things come off the patent cliff, that pool gets smaller. And so that’s less money to invest in R&D, that’s less money for commercial incentives, that’s less money for rebates, that influenced the way that retailers behave and interact with their suppliers,” Davis says.
Sunrise Cooperative decided a quarter century ago that it could not keep every basic manufacturer happy, and said so out loud.
“We started a long time ago—25, 30 years ago – to evaluate our organization’s size. We’re not big enough to keep all the basic manufacturers happy. So you’ve got to pick a partner or two,” says Miller. “And to the rest, we were upfront and honest: we’re just not big enough to keep all of you happy. So there’s no use wasting your time or ours chasing these rabbits. Here’s who we’re going to align with,” he says.
Davis says the squeeze is structural.
“When there is the incentive and higher profit margin that you can generate for white labels, I can understand why a retailer would say, well, why would I trap myself in this model, and why would I not shift over towards this one that’s more favorable and gives me more control?” Davis says. “On the commercial side, there are considerations like, does it create channel conflict with my existing suppliers? Are there times where, if I do source something that’s white label or generic from another provider, does that mean I also lose my relationship fully with an agrochemicals company and lose the rest of that portfolio?”
Nutrien’s Nathan Packer frames the same decision from the other end of the scale.
“If we’re not able to fulfill the needs of our customers and bring new innovation to them, then the value can be diminished,” he says. “It’s not proprietary versus the national brands. Our national brand partnerships bring critical chemistry, genetics, and traits , that’s important to customers today. But Loveland Products and Dyna-Gro give us the ability to add differentiated technologies, localized product fit, and the ability to tailor whole-acre solutions to specific agronomic challenges,” Packer says. “The relationships that we have with our national suppliers are just as important as the ability to focus on Loveland Products and Dyna-Gro Seed because the right answer depends on the acre, the agronomic challenge, and the grower’s goals.”
Pencil to paper, retailers are evaluating how they fill their product portfolio with margin in mind. The ensuing conversation about supplier relationships and proprietary brands is multi-layered.
The Margin Isn’t Free
Retailers are taking on more when they seek out the margin via a private labeled product. The clearest cost is inventory risk, which the branded system previously absorbed. That safety net doesn’t come with a private label.
“Customers are used to branded products that maybe carried a warranty of some type–then at the end of the season you could return it to distribution, and distribution sat on it and the company that manufactured it basically carried that product for you,” Miller says.
Miller says it’s meant Sunrise intentionally manages inventory with volume estimates because the cost of inventory surplus carries consequences owned by the coop.
And in a deflating market, the carry compounds.
“On the crop protection side, they’ll keep for a year or two. It’s not a big deal — other than the amount of money that it costs to carry them. And then in that generic market, that means next year it could be 10% lower. And you own next year’s inventory at a high level,” Miller says.
Davis frames the tradeoff as a change in the nature of the work rather than a simple transfer of risk.
“It also can potentially simplify a lot of the dynamics in agrochemicals that become complicated in operations, like the trade spend, like the rebates, like all the netbacks and inventory management and things that you have to do as part of an agrochemical manufacturer supplier program that — while you end up needing to be on the hook for them as a white label owner — it can potentially simplify the business and make it more of an operational play versus a negotiation play,” Davis says.
How to Cut the Pie
Retailer-led brands are shifting the industry differently by category. With off-patent crop protection, the profit pool is being redirected from manufacturers. The pie is being sliced differently. However, for biologicals, the pie itself is getting bigger.
“But where retailers are shifting the value pool in biologicals is they’re actually making it bigger for everyone, because they are opening up access to farmers that may not have ever come into contact with that product or considered it at all,” Davis says.
It’s the size of the biological companies that pairs well with retailers, when there’s product-market fit.
“If you think about biologicals, the average company in that space is 20 or 30 million dollars. And so, as an ag retailer, being able to put together a portfolio of those products together, or create products that are unique to you as a retailer can be interesting as well,” Davis says.
Whatever the category, the window is short.
“You’ve got about three years to make hay with a product before the infiltration of competition. It’s a pretty steep bell curve on the front side, and then the back side, once you get competitors joining the market, we all know what that’s like,” Jeff Corraini PCT sales and marketing lead says.
Read more about how leading retailers are taking their branded products to market in an upcoming story.
